HK1159113A1 - Pyridopyrimidine compounds as anti-tubercular agents - Google Patents

Pyridopyrimidine compounds as anti-tubercular agents

Info

Publication number
HK1159113A1
HK1159113A1 HK11113868.9A HK11113868A HK1159113A1 HK 1159113 A1 HK1159113 A1 HK 1159113A1 HK 11113868 A HK11113868 A HK 11113868A HK 1159113 A1 HK1159113 A1 HK 1159113A1
Authority
HK
Hong Kong
Prior art keywords
tubercular agents
pyridopyrimidine compounds
pyridopyrimidine
compounds
tubercular
Prior art date
Application number
HK11113868.9A
Other languages
English (en)
Chinese (zh)
Inventor
．布羅丹
．克裡斯托夫
盧載成
金在昇
．熱諾韋西奧
．費尼斯坦
全希暻
．埃旺
姜善姬
李世淵
徐旼廷
朴垠錚
．孔特雷拉斯多明格斯
南芝娟
金恩惠
Original Assignee
韓國巴斯德研究所
國家健康與醫學研究院
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 韓國巴斯德研究所, 國家健康與醫學研究院 filed Critical 韓國巴斯德研究所
Publication of HK1159113A1 publication Critical patent/HK1159113A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/63—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C255/65—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms
    • C07C255/66—Carboxylic acid nitriles containing cyano groups and nitrogen atoms further bound to other hetero atoms, other than oxygen atoms of nitro or nitroso groups, bound to the same carbon skeleton with the nitrogen atoms further bound to nitrogen atoms having cyano groups and nitrogen atoms being part of hydrazine or hydrazone groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/48—Two nitrogen atoms
    • C07D251/52—Two nitrogen atoms with an oxygen or sulfur atom attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/66—Derivatives of melamine in which a hetero atom is directly attached to a nitrogen atom of melamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK11113868.9A 2008-06-17 2011-12-22 Pyridopyrimidine compounds as anti-tubercular agents HK1159113A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13228508P 2008-06-17 2008-06-17
PCT/EP2009/004379 WO2010003533A2 (en) 2008-06-17 2009-06-17 Anti-infective compounds

Publications (1)

Publication Number Publication Date
HK1159113A1 true HK1159113A1 (en) 2012-07-27

Family

ID=41037902

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11113868.9A HK1159113A1 (en) 2008-06-17 2011-12-22 Pyridopyrimidine compounds as anti-tubercular agents

Country Status (10)

Country Link
US (2) US8785452B2 (ja)
EP (2) EP2730576A3 (ja)
JP (2) JP5739329B2 (ja)
KR (1) KR101574332B1 (ja)
CN (2) CN102105470B (ja)
AU (1) AU2009267519B2 (ja)
BR (1) BRPI0914254A2 (ja)
CA (1) CA2727651C (ja)
HK (1) HK1159113A1 (ja)
WO (1) WO2010003533A2 (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011085990A1 (en) * 2010-01-13 2011-07-21 Institut Pasteur Korea Anti - infective pyrido (1,2 -a) pyrimidines
HUP1000034A2 (en) * 2010-01-21 2011-09-28 Uratim Kft Pyrido[1,2-a]pyrimidine derivatives and pharmaceutical preparations thereof having anti - mycobacterial activity
PL2547678T3 (pl) 2010-03-18 2016-10-31 Związki przeciwzapalne
PL2565190T3 (pl) 2010-04-28 2015-10-30 Astellas Pharma Inc Związek tetrahydrobenzotiofenowy
WO2012006104A2 (en) 2010-06-28 2012-01-12 Academia Sinica, Taiwan Compounds and methods for treating tuberculosis infection
WO2012057599A1 (en) * 2010-10-25 2012-05-03 Universiti Sains Malaysia Anti-mycobacterial agents
WO2012103336A1 (en) 2011-01-26 2012-08-02 University Of Rochester Small molecule rnase inhibitors and methods of use
WO2012116010A2 (en) 2011-02-22 2012-08-30 The General Hospital Corporation Antibiotic tolerance inhibitors
US20130158112A1 (en) * 2011-06-20 2013-06-20 Jonathan D. SMITH Compositions and methods for inhibiting beta amyloid secretion
CN102871992A (zh) * 2011-09-30 2013-01-16 中国医学科学院医药生物技术研究所 3,5-二硝基苯甲酰胺在制备抗结核药物中的应用
US9453022B2 (en) * 2012-02-14 2016-09-27 Children's Hospital Medical Center Use of small molecule inhibitors targeting the interaction between Rac GTPase and p67 (phox)
KR20130118612A (ko) * 2012-04-20 2013-10-30 (주)네오믹스 신규한 아미노피리딘 유도체 및 이의 용도
WO2013192388A1 (en) 2012-06-20 2013-12-27 University Of Virginia Patent Foundation Compositions and methods for regulating glucose homeostasis and insulin action
KR102529578B1 (ko) 2014-08-29 2023-05-09 (주)아모레퍼시픽 신규 아다만탄 유도체 화합물
CN111961050A (zh) * 2014-12-02 2020-11-20 普拉纳生物技术有限公司 4H-吡啶并[1,2-a]嘧啶-4-酮化合物
CZ306245B6 (cs) * 2014-12-11 2016-10-26 Univerzita Karlova v Praze Farmaceutická fakulta v Hradci Králové Substituovaný fenyltetrazol, jeho použití a farmaceutický přípravek ho obsahující
CN105712931A (zh) * 2016-03-16 2016-06-29 山东师范大学 一种7-苯基-5-氧代-4-取代-1,4,5,6,7,8-六氢喹啉-3-羧酸乙酯及其无催化合成方法
EP3463338A4 (en) * 2016-05-27 2020-01-29 Arkansas State University-Jonesboro ANTIMICROBIAL AGENTS AND METHOD FOR SYNTHESIS OF ANTIMICROBIAL AGENTS
EP3600331A4 (en) * 2017-03-27 2022-03-09 The Regents of the University of Colorado, A Body Corporate SMALL MOLECULE BACTERIAL EFFLUX PUMP INHIBITORS AND METHODS OF USE THEREOF
WO2019040404A1 (en) * 2017-08-21 2019-02-28 Microbiotix, Inc. METABOLIC-STABLE METABOLIC-N-ACYLAMINOOXADIAZOLES USEFUL AS ANTIBACTERIAL AGENTS
US10357485B1 (en) 2018-09-27 2019-07-23 King Saud University Anti-cancer compound
GB2589912A (en) * 2019-12-12 2021-06-16 Chemestmed Ltd Method of suppressing cancer by RNA m6A methyltransferase mettl16 inhibitors
CN112336719A (zh) * 2020-10-19 2021-02-09 济南大学 一种噻唑衍生物作为α-葡萄糖苷酶抑制剂及其应用
CN113214249B (zh) * 2021-04-23 2023-09-19 成都大学 吡啶并[1,2-a]嘧啶-4-硫酮化合物的合成方法
KR20230113192A (ko) 2022-01-21 2023-07-28 재단법인 한국파스퇴르연구소 항박테리아 활성 옥사졸 유도체 화합물 및 이의 의약 용도
WO2024050040A2 (en) * 2022-08-31 2024-03-07 Texas Crop Science Apyrase inhibitors
EP4345092A1 (en) * 2022-09-29 2024-04-03 Faculdade de Farmácia da Universidade de Lisboa Nitrobenzamide compounds, methods and uses thereof
EP4345091A1 (en) * 2022-09-29 2024-04-03 Faculdade de Farmácia da Universidade de Lisboa Benzoic acid derivatives, methods and uses thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178910B (en) 1977-08-19 1982-07-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing 2,3-disubstituted-4-oxo-4h-pyrido/1,2-a/-pyrimidines
CA1283411C (en) 1985-09-25 1991-04-23 Masami Doteuchi 9-(substituted thio)-4h-pyrido[1,2-a]-pyrimidin-4-one derivatives
JPH0655740B2 (ja) 1985-09-25 1994-07-27 塩野義製薬株式会社 ピリドピリミジン誘導体
HU201551B (en) 1988-02-03 1990-11-28 Chinoin Gyogyszer Es Vegyeszet Process for producing 4-oxo-4h-pyrido(1,2-a)pyrimidine-3-carboxylic acid amide derivatives and pharmaceutical compositions comprising same
WO1993023398A1 (en) * 1992-05-13 1993-11-25 E.I. Du Pont De Nemours And Company Substituted pyrido[1,2-a]pyrimidinone derivatives as fungicides
FR2691460B1 (fr) * 1992-05-21 1994-07-22 Rhone Poulenc Rorer Sa Nouveaux derives du taxane, leur preparation et les compositions qui les contiennent.
AU2001232238B2 (en) * 2000-02-09 2005-03-24 Daiichi Pharmaceutical Co., Ltd. Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
US6645505B2 (en) * 2001-03-27 2003-11-11 Council Of Scientific And Industrial Research Reporter gene based method for the screening of anti-tuberculosis drugs by using essential and regulatory genes of mycobacteria as drug target
US20050009843A1 (en) * 2001-04-26 2005-01-13 Kiyoshi Nakayama Medicine for inhibiting drug elimination pump
AU2003269346A1 (en) * 2002-10-16 2004-05-04 Council Of Scientific And Industrial Research Screening method
WO2004037159A2 (en) * 2002-10-23 2004-05-06 Obetherapy Biotechnology Compounds, compositions and methods for modulating fat metabolism
CN1580276A (zh) * 2003-07-30 2005-02-16 中国科学院大连化学物理研究所 一种高通量抗结核杆菌药物的筛选方法
ZA200603113B (en) 2003-09-26 2007-08-29 Jubilant Organosys Ltd Process for the preparation of risperidone
WO2005089068A2 (en) * 2004-03-24 2005-09-29 Rimonyx Pharmaceuticals Ltd. Pharmaceutical compositions comprising anti-inflammatory quinazolinecarboxamide derivatives
CN101008029A (zh) * 2006-01-27 2007-08-01 中国医学科学院医药生物技术研究所 以结核杆菌异柠檬酸裂解酶为靶点的抗结核药物筛选模型
EP1916249A1 (en) * 2006-10-10 2008-04-30 LEK Pharmaceuticals D.D. 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents
CN1945324A (zh) * 2006-10-19 2007-04-11 复旦大学 一种筛选结核杆菌耐药蛋白的方法
JP2011132142A (ja) * 2009-12-22 2011-07-07 Kowa Co エリスロポエチン産生促進作用を有するフェニルオキサジアゾール化合物

Also Published As

Publication number Publication date
CN102105470A (zh) 2011-06-22
AU2009267519B2 (en) 2014-11-27
US8785452B2 (en) 2014-07-22
WO2010003533A3 (en) 2010-11-25
EP2730576A3 (en) 2014-09-03
US20150018543A1 (en) 2015-01-15
CN102105470B (zh) 2014-06-04
CA2727651A1 (en) 2010-01-14
EP2310388B1 (en) 2015-08-05
JP2015187110A (ja) 2015-10-29
US20110178077A1 (en) 2011-07-21
AU2009267519A1 (en) 2010-01-14
EP2310388A2 (en) 2011-04-20
BRPI0914254A2 (pt) 2015-11-03
CA2727651C (en) 2016-04-05
JP2011524391A (ja) 2011-09-01
KR101574332B1 (ko) 2015-12-08
KR20110029148A (ko) 2011-03-22
CN103983627A (zh) 2014-08-13
JP5739329B2 (ja) 2015-06-24
EP2730576A2 (en) 2014-05-14
WO2010003533A2 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
HK1159113A1 (en) Pyridopyrimidine compounds as anti-tubercular agents
GB0810902D0 (en) New compounds
GB0807862D0 (en) Compounds
GB0800035D0 (en) Compounds
GB0804702D0 (en) Compounds
IL210935A0 (en) Anti-malarial compounds
GB0809776D0 (en) Compounds
IL210344A0 (en) New compounds
GB0800367D0 (en) Compounds
HU0800478D0 (en) New compounds
GB0807910D0 (en) Compounds
GB0801220D0 (en) Compounds
GB0801265D0 (en) Compounds
GB0810792D0 (en) New compounds
GB0808669D0 (en) Compounds
GB0800455D0 (en) Compounds
GB0810892D0 (en) Compounds
GB0804064D0 (en) Compounds
GB0810619D0 (en) Compounds
GB0810118D0 (en) Compounds
GB0803496D0 (en) Compounds
GB0800338D0 (en) Compounds
GB0809771D0 (en) Compounds
GB0801219D0 (en) Compounds
GB0808471D0 (en) Inseticidal compounds

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20180617